The R&D Director of Cerbios, Alberto Terraneo talks us through their new Luggano based facility and its ability to produce complex cytotoxic linker-payloads for ADCs used in cancer therapies.
TWENTYFOURSEVENBIOPHARMA
The R&D Director of Cerbios, Alberto Terraneo talks us through their new Luggano based facility and its ability to produce complex cytotoxic linker-payloads for ADCs used in cancer therapies.